Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 3
1995 1
1998 1
1999 1
2000 1
2004 2
2005 1
2006 1
2007 2
2008 1
2009 2
2010 2
2012 2
2014 2
2015 2
2016 5
2017 5
2018 5
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Advances in development of new tuberculosis vaccines.
da Costa C, Onyebujoh P, Thiry G, Zumla A. da Costa C, et al. Among authors: onyebujoh p. Curr Opin Pulm Med. 2023 May 1;29(3):143-148. doi: 10.1097/MCP.0000000000000950. Epub 2023 Mar 2. Curr Opin Pulm Med. 2023. PMID: 36866744 Review.
Tuberculosis.
Onyebujoh P, Rook GA. Onyebujoh P, et al. Nat Rev Microbiol. 2004 Dec;2(12):930-2. doi: 10.1038/nrmicro1050. Nat Rev Microbiol. 2004. PMID: 15580691 No abstract available.
Laboratory medicine in Africa since 2008: then, now, and the future.
Nkengasong JN, Mbopi-Keou FX, Peeling RW, Yao K, Zeh CE, Schneidman M, Gadde R, Abimiku A, Onyebujoh P, Birx D, Hader S. Nkengasong JN, et al. Among authors: onyebujoh p. Lancet Infect Dis. 2018 Nov;18(11):e362-e367. doi: 10.1016/S1473-3099(18)30120-8. Epub 2018 Jul 3. Lancet Infect Dis. 2018. PMID: 29980383 Review.
Biomarkers for tuberculosis disease activity, cure, and relapse.
Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A. Wallis RS, et al. Among authors: onyebujoh p. Lancet Infect Dis. 2009 Mar;9(3):162-72. doi: 10.1016/S1473-3099(09)70042-8. Lancet Infect Dis. 2009. PMID: 19246020 Review.
Treatment Options for HIV-Associated Tuberculosis.
Onyebujoh PC, Ribeiro I, Whalen CC. Onyebujoh PC, et al. J Infect Dis. 2007 Aug 15;196 Suppl 1(Suppl 1):S35-45. doi: 10.1086/518657. J Infect Dis. 2007. PMID: 17726832 Free PMC article. Review.
Advances in immunotherapy for tuberculosis treatment.
Churchyard GJ, Kaplan G, Fallows D, Wallis RS, Onyebujoh P, Rook GA. Churchyard GJ, et al. Among authors: onyebujoh p. Clin Chest Med. 2009 Dec;30(4):769-82, ix. doi: 10.1016/j.ccm.2009.08.009. Clin Chest Med. 2009. PMID: 19925966 Review.
Treatment of tuberculosis: present status and future prospects.
Onyebujoh P, Zumla A, Ribeiro I, Rustomjee R, Mwaba P, Gomes M, Grange JM. Onyebujoh P, et al. Bull World Health Organ. 2005 Nov;83(11):857-65. Epub 2005 Nov 10. Bull World Health Organ. 2005. PMID: 16302043 Free PMC article. Review.
Sustainable clinical laboratory capacity for health in Africa.
Davies J, Abimiku A, Alobo M, Mullan Z, Nugent R, Schneidman M, Sikhondze W, Onyebujoh P. Davies J, et al. Among authors: onyebujoh p. Lancet Glob Health. 2017 Mar;5(3):e248-e249. doi: 10.1016/S2214-109X(17)30024-4. Epub 2017 Jan 18. Lancet Glob Health. 2017. PMID: 28108137 Free article. No abstract available.
42 results